1. KD. Tripathi. Haematinics and Erythropoietin. Essentials of medical pharmacology. Seventh edition. 2013. Page – 608-609.
2. Kenneth Kaushansky and Thomas J. Kipps. Hematopoietic agents: growth factors, minerals and vitamins. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1088-1092.
3. Troikaa Pharmaceuticals. Methylcobalamin nasal spray - Troikaa Pharmaceuticals. Adis Insight. [Revised on January 2019] [Accessed 26th November 2020] https://adisinsight.springer.com/drugs/800047619
4. Amrita Sil, Hrishikesh Kumar, Rahul Deb Mondal, Sidharth Sankar Anand, Anirban Ghosal, Ashis Datta, Sandesh V Sawant, Vaibhavi Kapatkar, Ganesh Kadhe and Sameer Rao. A randomized, open labeled study comparing the serum levels of cobalamin after three doses of 500 mcg vs. a single dose methylcobalamin of 1500 mcg in patients with peripheral neuropathy. NCBI; PMC US National Library of Medicine, National Institute of Health. July 2018. [Accessed 25th November 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037815/
5. Par Pharmaceutical, Inc. NASCOBAL- cyanocobalamin spray. [Revised on February 2020] [Accessed 26th November 2020] https://www.endo.com/File%20Library/Products/Prescribing%20Information/NASCOBAL_prescribing_information.html
6. Par Pharmaceutical, Inc. U.S. Food & Drug Administration. [Accessed 26th November 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021642Orig1s015lbl.pdf